If you are still having problems viewing this message, please click here for additional help.

British Journal of Cancer
Scientific Reports Editor's choice collection: Tumour Microenvironment Researchers are unravelling the dynamics of tumour microenvironments to understand how to model, define and fight tumours using multidisciplinary approaches. This collection presents a selection of articles from a variety of fields outlining some of the work being done within this growing research topic. Access the collection >>>
TABLE OF CONTENTS

Volume 119, Issue 2

In this issue
Announcement
Review Article
Article
Correspondence
Also new
AOP
 

Announcement

Referee acknowledgement for 2017

 

British Journal of Cancer 2018 119 :135 - 140; July 13, 2018; 10.1038/s41416-018-0151-5

 

Abstract | Full Text

Review Article

BRCA1/2 testing: therapeutic implications for breast cancer management

Nadine M. Tung & Judy E. Garber

British Journal of Cancer 2018 119 :141 - 152; June 05, 2018; 10.1038/s41416-018-0127-5

 

Abstract | Full Text

Article

Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012

Ranee Mehra, Tanguy Y. Seiwert, Shilpa Gupta, Jared Weiss, Iris Gluck et al.

British Journal of Cancer 2018 119 :153 - 159; June 29, 2018; 10.1038/s41416-018-0131-9

 

Abstract | Full Text

The efficacy of VEGFR TKI therapy after progression on immune combination therapy in metastatic renal cell carcinoma

Pedro Coelho Barata, Alfonso Gomez De Liano, Prateek Mendiratta, Valerie Crolley, Bernadett Szabados et al.

British Journal of Cancer 2018 119 :160 - 163; May 24, 2018; 10.1038/s41416-018-0104-z

 

Abstract | Full Text

Predictive potential of tumour-stroma ratio on benefit from adjuvant bevacizumab in high-risk stage II and stage III colon cancer

Stéphanie M. Zunder, Gabi W. van Pelt, Hans J. Gelderblom, Christoph Mancao, Hein Putter et al.

British Journal of Cancer 2018 119 :164 - 169; May 14, 2018; 10.1038/s41416-018-0083-0

 

Abstract | Full Text

Early metabolic response in sequential FDG-PET/CT under cetuximab is a predictive marker for clinical response in first-line metastatic colorectal cancer patients: results of the phase II REMOTUX trial

Anne Katrin Berger, Stephan Lücke, Ulrich Abel, Georg Martin Haag, Carsten Grüllich et al.

British Journal of Cancer 2018 119 :170 - 175; July 02, 2018; 10.1038/s41416-018-0152-4

 

Abstract | Full Text

Nut consumption and the risk of oesophageal squamous cell carcinoma in the Golestan Cohort Study

Maryam Hashemian, Gwen Murphy, Arash Etemadi, Hossein Poustchi, Maryam Sharafkhah et al.

British Journal of Cancer 2018 119 :176 - 181; June 28, 2018; 10.1038/s41416-018-0148-0

 

Abstract | Full Text

Interaction of WBP2 with ERα increases doxorubicin resistance of breast cancer cells by modulating MDR1 transcription

Shuai Chen, Han Wang, Zhi Li, Jun You, Qiu-Wan Wu et al.

British Journal of Cancer 2018 119 :182 - 192; June 25, 2018; 10.1038/s41416-018-0119-5

 

Abstract | Full Text

Clinical, histological and molecular predictors of metastatic melanoma responses to anti-PD-1 immunotherapy

Frantz Dupuis, Laurence Lamant, Emilie Gerard, Nouritza Torossian, Leonor Chaltiel et al.

British Journal of Cancer 2018 119 :193 - 199; July 05, 2018; 10.1038/s41416-018-0168-9

 

Abstract | Full Text

Patients with early-stage oropharyngeal cancer can be identified with label-free serum proteomics

Anna Tuhkuri, Mayank Saraswat, Antti Mäkitie, Petri Mattila, Robert Silén et al.

British Journal of Cancer 2018 119 :200 - 212; July 02, 2018; 10.1038/s41416-018-0162-2

 

Abstract | Full Text

High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer

Päivi Sirniö, Anne Tuomisto, Taina Tervahartiala, Timo Sorsa, Kai Klintrup et al.

British Journal of Cancer 2018 119 :213 - 219; May 29, 2018; 10.1038/s41416-018-0136-4

 

Abstract | Full Text

Harnessing citizen science through mobile phone technology to screen for immunohistochemical biomarkers in bladder cancer

Peter Smittenaar, Alexandra K. Walker, Shaun McGill, Christiana Kartsonaki, Rupesh J. Robinson-Vyas et al.

British Journal of Cancer 2018 119 :220 - 229; July 11, 2018; 10.1038/s41416-018-0156-0

 

Abstract | Full Text

Integrative analysis of oncogenic fusion genes and their functional impact in colorectal cancer

Yuri Choi, Chae Hwa Kwon, Seon Jin Lee, Joonghoon Park, Jong-Yeon Shin et al.

British Journal of Cancer 2018 119 :230 - 240; June 29, 2018; 10.1038/s41416-018-0153-3

 

Abstract | Full Text

Evaluation of efficacy and safety of sorafenib in kidney cancer patients aged 75 years and older: a propensity score-matched analysis

Katsunori Tatsugami, Mototsugu Oya, Koki Kabu & Hideyuki Akaza

British Journal of Cancer 2018 119 :241 - 247; June 12, 2018; 10.1038/s41416-018-0129-3

 

Abstract | Full Text

Adiposity and risks of colorectal and small intestine cancer in Chinese adults: a prospective study of 0.5 million people

Yuanjie Pang, Christiana Kartsonaki, Yu Guo, Yiping Chen, Ling Yang et al.

British Journal of Cancer 2018 119 :248 - 250; June 06, 2018; 10.1038/s41416-018-0124-8

 

Abstract | Full Text

Determinants of willingness to receive healthy lifestyle advice in the context of cancer screening

Claire Stevens, Charlotte Vrinten, Samuel G. Smith, Jo Waller & Rebecca J. Beeken

British Journal of Cancer 2018 119 :251 - 257; July 11, 2018; 10.1038/s41416-018-0160-4

 

Abstract | Full Text

Correspondence

Comment on ‘Dairy, calcium, vitamin D, and ovarian cancer risk in African-American women’

Constance Hilliard

British Journal of Cancer 2018 119 :258 - 259; July 02, 2018; 10.1038/s41416-018-0166-y

 

Abstract | Full Text

Reply to ‘Comment on ‘Dairy, calcium, vitamin D and ovarian cancer risk in African–American women’’

Bo Qin, Lauren C. Peres, Joellen M. Schildkraut & Elisa V. Bandera

British Journal of Cancer 2018 119 :260 - 262; July 02, 2018; 10.1038/s41416-018-0163-1

 

Abstract | Full Text

Advertisement
Nature Briefing is an essential round-up of science news, opinion and analysis, free in your inbox every weekday. With Nature Briefing, we'll keep you updated on the latest research, so you can focus on yours.

Click here to sign up.
nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to British Journal of Cancer.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature